Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):1–6. doi:10.3322/caac.21660.
   Web of Science ®Google Scholar
• World health organization, fact sheet, cervical cancer. 2022 Feb 22 [accessed 2022 May 29]. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer#: :text=HPV%20vaccines%20work%20best%20if,in%20males%20as%20well%20as.
   Google Scholar
• Cancer Statistics. Cancer information service, national cancer center, Japan (vital statistics of Japan, ministry of health, labour and welfare). [in Japanese]. [accessed 2022 May 29]. https://ganjoho.jp/reg_stat/statistics/stat/summary.html.
   Google Scholar
• Ueda Y, Yagi A, Nakayama T, Hirai K, Ikeda S, Sekine M, Miyagi E, Enomoto T. Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year. Sci Rep. 2018;8(1):5612. doi:10.1038/s41598-018-23947-6.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Ueda Y, Hara M, Yagi A, Kitamura T, Kitamura Y, Konishi H, Kakizoe T, Sekine M, Enomoto T, et al. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: a nationwide case-control study. Cancer Sci. 2021;112(2):839–46. doi:10.1111/cas.14682.
   PubMed Web of Science ®Google Scholar
• Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084–89. doi:10.1016/S0140-6736(21)02178-4.
   PubMed Web of Science ®Google Scholar
• World health organization, HPV vaccine included national immunization programe. [accessed 2022 Sept 4]. https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9.
   Google Scholar
• Giuliano AR Ph.D., Palefsky JM M.D., Goldstone S M.D., Moreira ED Jr., M.D., Penny ME M.D., Aranda C M.D., Vardas E M.D., Moi H M.D., Jessen H M.D., Hillman R M.D., et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11. doi:10.1056/NEJMoa0909537.
   PubMed Web of Science ®Google Scholar
• Patel C, Brotherton JML, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23(41):30–40. doi:10.2807/1560-7917.ES.2018.23.41.1700737.
   Google Scholar
• Katsuta T, Moser CA, Feemster KA, Saitoh A, Offit PA. Comparison of immunization systems in Japan and the United States–What can be learned? Vaccine. 2020;38:7401–08.
   PubMed Web of Science ®Google Scholar
• The ministry of health, labour and welfare. 2013 June 14. [in Japanese]. [accessed 2022 May 29]. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/index.html
   Google Scholar
• The ministry of health, labour and welfare. 2013 June 14. [in Japanese]. [accessed 29 May 2022]. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/pdf/kankoku_h25_6_01.pdf.
   Google Scholar
• The statement of global advisory committee on vaccine safety. 2015 Dec 2–3 [accessed 2022 May 29]. https://www.who.int/publications/i/item/who-wer9103-21-32.
   Google Scholar
• National Expert Committee for Vaccine Safety, Ministry of Health, Labour and Welfare, Japan. A nationwide epidemiological survey of adolescent patients with diverse symptoms including pain and motor dysfunction (material 4 at the meeting held in December 26, 2016). [in Japanese]. [accessed 2022 May 29]. https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000147016.pdf.
   Google Scholar
• Fukushima W, Hara M, Kitamura Y, Shibata M, Ugawa Y, Hirata K, Oka A, Miyamoto S, Kusunoki S, Kuwabara S, et al. A nationwide epidemiological survey of adolescent patients with diverse symptoms similar to those following human papillomavirus vaccination: background prevalence and incidence for considering vaccine safety in Japan. J Epidemiol. 2022;32(1):34–43. doi:10.2188/jea.JE20210277.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res. 2018;5:96–103.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, Miyagi E, Sekine M, Enomoto T, Kudoh K. HPV vaccination in Japan: what is happening in Japan? Expert Rev Vaccines. 2019;18(4):323–25. doi:10.1080/14760584.2019.1584040.
   PubMed Web of Science ®Google Scholar
• Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, et al. Japan’s ongoing crisis on HPV vaccination. Vaccines. 2020;8(3):362. doi:10.3390/vaccines8030362.
   Web of Science ®Google Scholar
• Sawada M, Ueda Y, Yagi A, Morimoto A, Nakae A, Kakubari R, Abe H, EgawaTakata T, Iwamiya T, Matsuzaki S, et al. HPV vaccination in Japan: results of a 3year followup survey of obstetricians and gynecologists regarding their opinions toward the vaccine. Int J Clin Oncol. 2018;23(1):121–25. doi:10.1007/s10147-017-1188-9.
   PubMed Web of Science ®Google Scholar
• Nagase Y, Ueda Y, Abe H, Yagi A, Sawada M, Nakagawa S, Hiramatsu K, Egawa-Takata T, Matsuzaki S, Kobayashi E, et al. Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine. Hum Vaccines Immunother. 2020;16(8):1808–13. doi:10.1080/21645515.2020.1712173.
   PubMed Web of Science ®Google Scholar
• EgawaTakata T, Ueda Y, Morimoto A, Tanaka Y, Matsuzaki S, Kobayashi E, Yoshino K, Sekine M, Enomoto T, Kimura T. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan. Int J Clin Oncol. 2016;21(1):53–58. doi:10.1007/s10147-015-0869-5.
   PubMed Web of Science ®Google Scholar
• Oka E, Ueda Y, Nagase Y, Sawada M, EgawaTakata T, Yagi A, Kakuda M, Nakagawa S, Hiramatsu K, Miyoshi A, et al. Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan. Int J Clin Oncol. 2022;27(8):1356–63. doi:10.1007/s10147-022-02173-1.
   PubMed Web of Science ®Google Scholar
• Vadaparampil ST, Kahn JA, Salmom D, Lee J, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011;29(47):8634–41. doi:10.1016/j.vaccine.2011.09.006.
   PubMed Web of Science ®Google Scholar
• Gilkeya MB, McReeb A-L. Provider communication about HPV vaccination: a systematic review. Hum Vaccines Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090.
   PubMed Web of Science ®Google Scholar
• Kearney MD, Selvan P, Hauer MK, Leader AE, Massey PM. Characterizing HPV vaccine sentiments and content on instagram. Health Educ Behav. 2019;46(2_suppl):37S–48S. doi:10.1177/1090198119859412.
   PubMed Web of Science ®Google Scholar
• Patel PR, Berenson AB. Sources of HPV vaccine hesitancy in parents. Hum Vaccin Immunother. 2013;9(12):2649–53. doi:10.4161/hv.26224.
   PubMed Web of Science ®Google Scholar